Back to News
Market Impact: 0.15
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Syndax Pharmaceuticals, Inc.- SNDX
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP announced an investigation into claims on behalf of investors in Syndax Pharmaceuticals (NASDAQ: SNDX). The notice provides contact details for investors but does not specify the claims, alleged conduct, or any financial impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
SNDX-0.65
More News
- Mizuho reiterates Outperform on Syndax stock, $43 target
- Meta says automation wrongly took down No Kings and a Senate candidate’s page. It’s automating more anyway
- Baron & Budd and Douglas & London Obtain $7.350 Billion Settlement With 3M Company to Resolve PFAS Personal Injury Lawsuits
- Booking Holdings takes $1 billion hit to third-quarter results linked to FTC action
- OpenAI’s hiring of former Army Secretary just 2 months after Pentagon resignation is part of a ‘trend’ of it pivoting resources to defense projects
- Midterm elections could jolt stocks if Democrats sweep Congress